<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>Centre for Discovery Brain Sciences</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/9E914223-C27C-4931-937A-02A79D4A0E5D"><gtr:id>9E914223-C27C-4931-937A-02A79D4A0E5D</gtr:id><gtr:firstName>Jamie</gtr:firstName><gtr:surname>Davies</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FK010735%2F1"><gtr:id>B665F739-7006-4DEB-97EF-18CA6FB40219</gtr:id><gtr:title>Functional testing of kidneys tissue-engineered from renogenic stem cells.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/K010735/1</gtr:grantReference><gtr:abstractText>Lay summary

This project is about a new approach to the challenge of engineering complex organs for medical purposes.

One of the most pressing goals of biological engineering is to find a way to make a functioning, transplantable organ from a simple culture of stem cells. Success in this area will bring direct benefits to patients, economic relief to the NHS and taxpayer, and will provide significant opportunity for industries who take up the challenge of producing organs to order. 

Existing work in the biotech industries has centred mainly on making clinical grade stem cells and setting them up to make specific tissues. The gap between cultures of stem cells, which are essentially un-arranged, and the highly intricate anatomical arrangements of complex organs such as kidney remains unbridged. Until the gap is bridged, stem cells will be of only very limited practical use for patients with serious organ failures.

We have recently developed and published a novel engineering technique for turning a simple suspension of individual foetal stem cells into a 'mini-kidney', essentially identical to a real foetal kidney except that it has no blood system. We now propose to engineer in a blood system, and to test the ability of our engineered kidneys to filter blood and excrete substances as a normal kidney would. We also propose to test how robust our method is (how well it corrects errors automatically, as we expect it to).

The direct impact of this project will be to provide an engineering technique by which kidney stem cells can be used to build real organs, potentially useful for transplants. In addition, we expect our technique to be applicable to other organs and tissues, so it may have a much broader impact in the general area of biological engineering.</gtr:abstractText><gtr:technicalSummary>This proposal addresses a priority area of MRC-MCMB: tissue engineering for regenerative medicine. It will test the physiological function of 'kidneys' tissue-engineered by a method developed in this lab: an important step in closing the gap between cultured stem cells and transplantable organs.

We have published a 2-step technique that turns suspensions of embryonic kidney stem cells into all of the epithelial and mesenchymal structures of a typical foetal kidney (Bowman's capsule, proximal and distal tubule, collecting duct, stroma etc), arranged and connected correctly, and we have pilot data showing that these engineered kidneys will become vascularized and will filter blood when transplanted into an adult host. We now wish to test, robustly and quantitatively, their functional ability:

1) We will add endothelial cells, grafted vessels in normal culture, and chick endothelia in chorioallantoic membrane (CAM) culture, to assess the ability of engineered kidneys to construct an anatomically-correct blood system.
2) We will use the fact that blood will be flowing in the CAM system (powered by the chick embryo heart) to test glomerular filtration using a standard labelled tracer method.
3) We will test active transport of organic anions and cations in the proximal tubules using labelled tracers: this will not depend on the success of parts 1 and 2 because it does not require flowing blood.
4) We will assess the robustness of the engineering system and its ability to self-correct deliberately-introduced errors of cell balance and arrangement. We have theoretical grounds to expect this.

Overall, this proposal advances our existing re-creation of basic renal anatomy to determining functional attributes. Afterwards, if the engineered organs perform as well as we expect, we can justify testing their ability to substitute for natural kidney function when matured in adult hosts. The self-organization based technology has more general biotech implications.</gtr:technicalSummary><gtr:potentialImpactText>Impact Summary 

There are 5 main classes of beneficiaries; they are listed here in order of immediacy (time) of direct impact;
1 - Academic bio-engineers (impact within time-scale of project)
2 - Biotech industry (impact probably just after project, maybe during)
3 - Public (meaningful impact several years away, but along a clear development path).
4 - Government (ditto).
5 - Third sector (ditto).

Academic research: Direct benefit to others trying to engineer complex tissues, as our technique is probably applicable far beyond the kidneys on which this project will focus. This impact on the academic community that can broaden the range of applicability of the engineering technique is a multiplier of all of the benefits below. There is also a small benefit to basic scientific understanding, which is detailed in the Case for Support section. 

Biotech: The most direct benefit to biotech will be a viable engineering path from stem cells to *complex* organs (at the moment, only simple tissues can be made). This is a big multiplier of value already invested in stem cell technology, and can impact profit, growth and range of application. The type of work is ideally suited to UK SMEs. A second, small effect, comes from the training of people (who attend our proposed workshop, open to industry as well as academia) in exactly these techniques. Biotech, as well as academia, can research applying our engineering techniques to other tissues and organs.

Public: the shortage of transplantable kidneys (waiting list c. 7000 and growing) causes significant suffering (dialysis is painful, time-consuming and robs people of freedom and productivity). A technique for engineering kidneys from stem cells would provide great benefit; even more if it could be applied to other organs too. Plus, of course, indirect benefits from growth of a vibrant biotech industry.

Government: Maintaining kidney patients on dialysis is doubly expensive; directly to the NHS and also in respect to loss of time from individuals hooked up to a dialysis machine when they could be productive. Production of transplantable organs would alleviate both problems. ALSO, government research councils have ploughed a lot of money into stem cells without much to show for it in terms of a medical advance that the taxpayer can see and feel has been value. Having a bridge from stem cells to organs would be a valuable concrete example of why funding research is useful.

Third Sector: medical charities will have the same benefit as mentioned above for government research councils.</gtr:potentialImpactText><gtr:fund><gtr:end>2017-07-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-08-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>364700</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>The Roslin Institute</gtr:department><gtr:description>Peter Hohenstein Renal Development</gtr:description><gtr:id>3673214E-7E26-456A-9606-57A7B25EE560</gtr:id><gtr:impact>6 published research papers, two more in current review, nd several joint grant applications.</gtr:impact><gtr:outcomeId>qBdAQPcXYLm-1</gtr:outcomeId><gtr:partnerContribution>Expertise in genetic manipulation of mice and mouse cells.</gtr:partnerContribution><gtr:piContribution>Expertise in renal organ culture, engineering and physiological measurement</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Renotox collaboration wiht A-Z</gtr:description><gtr:id>EF0EBD9A-412E-4C77-B35F-2CA9EE646B36</gtr:id><gtr:impact>Currently confidential under our agreement with Astra-Zeneca</gtr:impact><gtr:outcomeId>5894619481a5b7.83403639-1</gtr:outcomeId><gtr:partnerContribution>Expertise in toxicology, and a blind-coded panel of reagents</gtr:partnerContribution><gtr:piContribution>Expertise in in vitro renal organoids</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Pint of Science presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>5E85666D-2781-4595-9E30-EC48E8FD8048</gtr:id><gtr:impact>Pint of Science pub-based talk and demonstration.</gtr:impact><gtr:outcomeId>58945bf68fa6d7.69770552</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Broadcast on BBC World Service</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>CE6688B8-F474-4253-8FC3-6B2EAB7D3A66</gtr:id><gtr:impact>Participation in a 3-way discussion (+ Bridget Kendal as Chair) for a 50-minute BBC World Service &amp;quot;Forum&amp;quot; programme, on mechanisms of self-assembly and self-organization. This included discussion of the MRC-funded renal tissue engineering project, and the BBSRC-funded synthetic morphology project although I am afraid the specific sentence about funding this was lost on the edit.

No directly measurable ones (and none were expected - this was about show-casing an interesting field of science to a world-wide pubic audience).</gtr:impact><gtr:outcomeId>544134d813b6e2.25030243</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.bbc.co.uk/programmes/p027gcpk</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>A tissue engineering approach to reduce animal use in renal development and renal organ replacement technology</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DBC8412F-4721-4004-A967-57FC9E2C7920</gtr:id><gtr:impact>About 70 scientists attended, and discussed this work. Informal discussions afterwards led to the dissemination impacts below.

Dissemination of cell lines created in the project to other labs (France, UK, Australia), and dissemination of ordering details vie www.gudmap.org database.</gtr:impact><gtr:outcomeId>537b01411b6dd</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation of Young European Scientist's Event</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>55F9DBF2-7336-440F-A327-6455A94D0647</gtr:id><gtr:impact>Talk and workshop at the Young European Scientist's Meeting at Porto (which, despite the name, is actually mainly medical students from around Europe)</gtr:impact><gtr:outcomeId>589460ac4c3660.09568347</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public talk at Aye Write (Glasgow literary festival)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0A7DFA83-8AE6-486E-88A7-C1C61AA2EEFD</gtr:id><gtr:impact>About 60 people attended a talk on human development, with some discussion afterwards, both about the talk and about career paths into science.

One school pupil came to shadow someone in the lab for a week.</gtr:impact><gtr:outcomeId>54413633e8fe35.25391290</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>197000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Kindey Research UK Project Grants</gtr:description><gtr:end>2019-08-02</gtr:end><gtr:fundingOrg>Kidney Research UK</gtr:fundingOrg><gtr:fundingRef>RP_002_20160223</gtr:fundingRef><gtr:id>91085CE6-7E6F-4D0C-ADFA-D63F69D8FBFC</gtr:id><gtr:outcomeId>589478158e1e29.37622078</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>The new thing is a method, to be used on tissue-engineered kidneys (which are also a research material from this lab, but from earlier grants).</gtr:description><gtr:id>D0A5CFA8-3954-473D-9240-1855736B9B27</gtr:id><gtr:impact>We are only in month 4 of our 36 month grant - we have this method working, and will use it for the stated aims of this grant. (We have just submitted a paper describing it, to Scientific Reports)</gtr:impact><gtr:outcomeId>JK54hSXENtq</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Method for testing renal transport in micro-culture</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>9633A06D-2B5C-4EC7-BEB7-5FB704716D1F</gtr:id><gtr:title>Adaptive self-organization in the embryo: its importance to adult anatomy and to tissue engineering.</gtr:title><gtr:parentPublicationTitle>Journal of anatomy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3536303e447ef0140ef80828b19342d1"><gtr:id>3536303e447ef0140ef80828b19342d1</gtr:id><gtr:otherNames>Davies JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0021-8782</gtr:issn><gtr:outcomeId>5a2f905364d0b4.75443593</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C14FB366-8FB4-4BA4-82A8-BBB822604B5D</gtr:id><gtr:title>Node retraction during patterning of the urinary collecting duct system.</gtr:title><gtr:parentPublicationTitle>Journal of anatomy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/964da68b033600758a79b66d7b730cd7"><gtr:id>964da68b033600758a79b66d7b730cd7</gtr:id><gtr:otherNames>Lindstr?m NO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-8782</gtr:issn><gtr:outcomeId>542bcb75e2a8e1.55411226</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E11F590-C60D-477C-8AE7-47B5163AE81B</gtr:id><gtr:title>Biological techniques: Kidney tissue grown from induced stem cells.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3536303e447ef0140ef80828b19342d1"><gtr:id>3536303e447ef0140ef80828b19342d1</gtr:id><gtr:otherNames>Davies JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56b8936597abb0.95253392</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>324ABABE-A75F-4553-8055-7912628AB618</gtr:id><gtr:title>Deducing the stage of origin of Wilms' tumours from a developmental series of Wt1-mutant mice.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8602f44e42021651bd556f52b0eb8f5"><gtr:id>f8602f44e42021651bd556f52b0eb8f5</gtr:id><gtr:otherNames>Berry RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn><gtr:outcomeId>5675e5b07b813</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67DA7E16-06C3-4ABF-BE43-5F8724B8E5E3</gtr:id><gtr:title>Asymmetric BMP4 signalling improves the realism of kidney organoids.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ac33f8929af5b3f61c04aeeb5cf73bd"><gtr:id>7ac33f8929af5b3f61c04aeeb5cf73bd</gtr:id><gtr:otherNames>Mills CG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a2f90f1e7da46.98931423</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D9FB4002-DA55-4612-8A38-5A5A1A67D7D5</gtr:id><gtr:title>Pax2: A &amp;quot;Keep to the Path&amp;quot; Sign on Waddington's Epigenetic Landscape.</gtr:title><gtr:parentPublicationTitle>Developmental cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77654537111c473e3f16947aa03d7fa6"><gtr:id>77654537111c473e3f16947aa03d7fa6</gtr:id><gtr:otherNames>Davies J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1534-5807</gtr:issn><gtr:outcomeId>5a2f905434ff79.75827132</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C4619E1-0857-4527-B37B-801A454B6012</gtr:id><gtr:title>Engineered renal tissue as a potential platform for pharmacokinetic and nephrotoxicity testing.</gtr:title><gtr:parentPublicationTitle>Drug discovery today</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77654537111c473e3f16947aa03d7fa6"><gtr:id>77654537111c473e3f16947aa03d7fa6</gtr:id><gtr:otherNames>Davies J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1359-6446</gtr:issn><gtr:outcomeId>542bcbb2cb28e6.79356294</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E996C99A-67E9-4B99-8B36-CF54685B77BB</gtr:id><gtr:title>Transport of organic anions and cations in murine embryonic kidney development and in serially-reaggregated engineered kidneys.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ed3e70ddbf509cf3f45292db881dc82"><gtr:id>6ed3e70ddbf509cf3f45292db881dc82</gtr:id><gtr:otherNames>Lawrence ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>doi_55f98698679a9182</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F91E165E-D3D7-494B-930B-3B47F1AF1A0F</gtr:id><gtr:title>Life Unfolding</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3536303e447ef0140ef80828b19342d1"><gtr:id>3536303e447ef0140ef80828b19342d1</gtr:id><gtr:otherNames>Davies JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:isbn>978-0-19-967353-7</gtr:isbn><gtr:outcomeId>544137b7376a16.82093223</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7DF7C951-BEE1-4465-A870-07C91B9CE3C3</gtr:id><gtr:title>Cell-cell interactions driving kidney morphogenesis.</gtr:title><gtr:parentPublicationTitle>Current topics in developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bca078c1bee5ded940cebae57415e871"><gtr:id>bca078c1bee5ded940cebae57415e871</gtr:id><gtr:otherNames>Combes AN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0070-2153</gtr:issn><gtr:outcomeId>56b88f4da6c9f0.91494295</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0C463DE-1B67-4BF1-A244-D265936F5E15</gtr:id><gtr:title>Engineered kidneys: principles, progress, and prospects</gtr:title><gtr:parentPublicationTitle>Advances in Regenerative Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77654537111c473e3f16947aa03d7fa6"><gtr:id>77654537111c473e3f16947aa03d7fa6</gtr:id><gtr:otherNames>Davies J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>542bcc19455523.55214372</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>17BAD9CB-0822-467C-A809-AC48FEF43A10</gtr:id><gtr:title>Cycles of vascular plexus formation within the nephrogenic zone of the developing mouse kidney.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e81c6c3221ab6ebfa513dc0dfc5c601e"><gtr:id>e81c6c3221ab6ebfa513dc0dfc5c601e</gtr:id><gtr:otherNames>Munro DAD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a2f9054059496.52179974</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F324110-8EC5-4413-BFAF-4D46C19F944F</gtr:id><gtr:title>The inter-dependence of basic and applied biomedical sciences: Lessons from kidney development and tissue-engineering</gtr:title><gtr:parentPublicationTitle>Porto Biomedical Journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77654537111c473e3f16947aa03d7fa6"><gtr:id>77654537111c473e3f16947aa03d7fa6</gtr:id><gtr:otherNames>Davies J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a2f90548c0547.07102201</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0BA4AFD7-C135-46BA-8D8E-A10AFCC54037</gtr:id><gtr:title>The Origins and Functions of Tissue-Resident Macrophages in Kidney Development.</gtr:title><gtr:parentPublicationTitle>Frontiers in physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e81c6c3221ab6ebfa513dc0dfc5c601e"><gtr:id>e81c6c3221ab6ebfa513dc0dfc5c601e</gtr:id><gtr:otherNames>Munro DAD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1664-042X</gtr:issn><gtr:outcomeId>5a2fd749821375.94715643</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B8EFE70-9DFA-4099-A830-CC7D2EECB5C7</gtr:id><gtr:title>Engineering kidneys from simple cell suspensions: an exercise in self-organization.</gtr:title><gtr:parentPublicationTitle>Pediatric nephrology (Berlin, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3536303e447ef0140ef80828b19342d1"><gtr:id>3536303e447ef0140ef80828b19342d1</gtr:id><gtr:otherNames>Davies JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0931-041X</gtr:issn><gtr:outcomeId>542bcbe65569e5.34745977</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03ADC33E-04E2-4AEB-BC9D-E64E9CC4F0BD</gtr:id><gtr:title>Refuting the hypothesis that semaphorin-3f/neuropilin-2 exclude blood vessels from the cap mesenchyme in the developing kidney.</gtr:title><gtr:parentPublicationTitle>Developmental dynamics : an official publication of the American Association of Anatomists</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e81c6c3221ab6ebfa513dc0dfc5c601e"><gtr:id>e81c6c3221ab6ebfa513dc0dfc5c601e</gtr:id><gtr:otherNames>Munro DAD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1058-8388</gtr:issn><gtr:outcomeId>5a2fd8b83f8aa6.65447893</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/K010735/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>2EEE0958-6BE1-4D16-B86B-5D954CD37219</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Renal and Urogenital</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>DD81206B-5EB4-4BCC-AEF7-808A64606E0E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>